Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake
Authors:
- E.E. BeedleEBE.E. Beedle
- J. FindlayJFJ. Findlay
- P.T. GallagherPGP.T. Gallagher
- J.H. KrushinskiJKJ.H. Krushinski
- S. MitchellSMS. Mitchell
- D.W. RobertsonDRD.W. Robertson
- D.C. ThompsonDTD.C. Thompson
- L. WallaceLWL. Wallace
- D.T. WongDWD.T. Wong
- 1 December 2003
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (24) , 4477-4480
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Duloxetine, 60 mg Once Daily, for Major Depressive DisorderThe Journal of Clinical Psychiatry, 2002
- Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitorsThe British Journal of Psychiatry, 2001
- An asymmetric synthesis of duloxetine hydrochloride, a mixed uptake inhibitor of serotonin and norepinephrine, and its C‐14 labeled isotopomersJournal of Labelled Compounds and Radiopharmaceuticals, 1995
- LY248686, A New Inhibitor of Serotonin and Norepinephrine UptakeNeuropsychopharmacology, 1993
- Asymmetric synthesis and absolute stereochemistry of LY248686Tetrahedron Letters, 1990
- MODERN FRIEDEL-CRAFTS CHEMISTRY XVI. REACTION OF THIOPHENE WITH BIFUNCTIONAL MOLECULES UNDER DIFFERENT FRIEDEL-CRAFTS CATALYSTS: ATTEMPTED SYNTHESIS OF CYCLOPENTA[b] THIOPHENES AND DIHYDROBENZO[b] THIOPHENESPhosphorus and Sulfur and the Related Elements, 1987
- 2,3-Dihydro and carbocyclic analogs of tryptamines: interaction with serotonin receptorsJournal of Medicinal Chemistry, 1982